Press release

DSM updates financial markets at its Capital Markets Day

Heerlen, NL, 05 Nov 2014 08:15 CET

Royal DSM, the global Life Sciences and Materials Sciences company, today will provide investors with an update on its strategic progress and current priorities at its annual Capital Markets Day, which will be held in London, United Kingdom.

Feike Sijbesma, CEO and Chairman of the DSM Managing Board, said: “DSM has made strong strategic progress, significantly transforming the company in recent years. In light of current market conditions, our focus is on improving the operational performance of our Nutrition and Performance Materials businesses, while continuing to pursue strategic actions for Polymer Intermediates and Composite Resins. We remain committed to long-term shareholder value generation.”

At the Capital Markets Day, DSM will provide an update on its strategic progress and operational performance and in that context will address:

  • Improving performance of the Nutrition and Performance Materials businesses
  • Initiatives focused on operational efficiencies and cash generation
  • Ongoing portfolio enhancement with strategic actions pursued for Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins
  • Expanding global presence
  • Value generation in the Pharma partnerships
  • Unlocking the value of innovation investments
  • Strict capital allocation

Webcast and presentations

The DSM Capital Markets Day can be followed live via audio webcast from 15.00-18.00 hrs (CET). The presentations can be found on this website as from 15.00 hrs (CET).

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420

Dave Huizing

Vice President Investor Relations
+31 45 578 2864

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864